0 Ebola outbreak in the Democratic Republic of Congo is second worst ever recorded
Ebola case numbers reach 426 in the current outbreak in the Democratic Republic of Congo, making this the second largest ever seen for the virus.
Browsing: Emerging Disease
0 First-ever multi-drug Ebola trial launched in the Democratic Republic of Congo
A new trial has begun in the Democratic Republic of Congo, aiming to collect robust data on the safety and efficacy of investigational Ebola therapeutics.
1 A peek behind the paper – Prof. Mohamed El Zowalaty on arboviral infections
Take a look behind the scenes of a recent Future Virology paper as we ask author Prof. Mohamed El Zowalaty about the challenges facing the field of arboviruses, from climate change to urbanization, both in South Africa and across the world.
0 FDA grants priority review for controversial dengue vaccine, Dengvaxia
The US FDA has granted priority review for Sanofi Pasteur’s dengue vaccine, Dengvaxia®, despite its controversial past.
0 Ebola nucleocapsid modeled to near-atomic resolution
A team from the Okinawa Institute of Science and Technology Graduate University has used cryo-EM to model the nucleocapsid protein of Ebola virus, potentially uncovering novel drug targets.
0 New species of Ebolavirus discovered in bats
The new species, the Bombali virus, has been identified in bats in Sierra Leone ahead of any human infection.
0 MERS-CoV case confirmed in England
Public Health England have confirmed that an individual has been diagnosed with MERS in England
0 Ebola vaccination initiated in North Kivu
Vaccination has begun to try and contain the second outbreak of Ebola seen in the Democratic Republic of Congo this year.
0 Dengue control: first citywide deployment of Wolbachia
The first citywide deployment of Wolbachia has proved successful, with no dengue cases reported since Wolbachia became established.
0 Calls for Ebola survivors to receive more specialist support
Following a study that shed new light on the psychiatric and neurological problems suffered by Ebola survivors, researchers are calling for more specialist support for this population.
